D2C Life Science, for optimized quality management D2C Life Science
Quality at the heart of the challenges of the pharmaceutical industry
The pharmaceutical sector is constantly evolving through the development of new therapies and the introduction of new technologies.
This development does not occur without bringing about
new regulatory and health issues
in order to avoid the patient risk from the production of the drug to its distribution.
Complying with regulations
while controlling risks as well as possible is essential for a pharmaceutical industry already strained by development and production costs, as well as distribution constraints.
It is in this context that evolves the company
D2C Life Science
(
Data Driven Compliance),
founded by Pascal Van de Veire and David Da Cunha, having themselves 25 years of managerial experience in this industry.
The company, whose head office is located in Alsace, meets the needs of customers located in Europe, but also in Asia and across the Atlantic, and
supports them in their quality approach
.
Personalized support towards excellence in quality
D2C Life Science
provides personalized support to its customers
in order to optimize quality management by adapting their organization and system to market constraints.
First of all, the evaluation of compliance with standards and knowledge of risks is compared with concrete data observed directly in the field in order to propose targeted solutions.
But beyond the simple mandatory compliance with standards, and the resolution of compliance gaps, D2C Life Science helps its customers achieve their Quality objectives through optimized design, reliable execution, and the development of predictive indicators.
.
The company offers comprehensive support, linking the aspects of risks, costs, capabilities and culture.
Its objective is to give an overall, discriminating and complete vision of the risks allowing
the right decisions to be made
on the basis of objective data.
Creating a strong partnership and a change of mindset beyond the consulting mission is essential for
a lasting result
.
This is why D2C Life Science ensures understanding of the obligations and seeks to increase the client's level of knowledge through a training and coaching process associated with each mission.
D2C Life Science aligns with Industry 4.0
In a world where the pharmaceutical industry is constantly digitizing, D2C Life Science aligns itself with this new mode of operation by
investing in a suite of software applications
integrating the 4 aspects of their model (Costs, Risks, Capabilities and Culture ).
This initiative launched in 2022 with a partner IT development company will continue in 2023 and 2024 for a comprehensive, reliable and predictive response to the challenges of the pharmaceutical industry in line with the evolution of the business towards Industry 4.0.
Would you like
more information about D2C Life Science
?
You can contact the co-founder Pascal Van De Veire at the following email address: pascal.vandeveire@d2c-lifescience.com